Dr. Mark T. Jennings

Dr. Rebecca Dezube is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are cystic fibrosis and critical care medicine. She sees patients in the adult cystic fibrosis (CF) clinic as well as in the medical intensive care unit (MICU). She received her A.B. from Harvard University and earned her M.D. from Vanderbilt University School of Medicine. She completed her residency in internal medicine at Johns Hopkins, where she also served as an Assistant Chief of Service. She also trained as a fellow in pulmonary and critical care medicine at Johns Hopkins and served as the Chief Fellow in Pulmonary and Critical Care Medicine. Dr. Dezube joined the Johns Hopkins faculty in 2017. Dr. Dezube is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), and Newborn Jaundice.

Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Dr. Michael Boyle is an Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine, and President and CEO of the U.S. Cystic Fibrosis Foundation. His areas of expertise include adult cystic fibrosis care and research. Dr. Boyle founded and directed the Johns Hopkins Adult Cystic Fibrosis Program from 1999 to 2015 at the Johns Hopkins Cystic Fibrosis Center. Dr. Boyle completed all of his medical training at Johns Hopkins including fellowship in pulmonary and critical care medicine before joining the Johns Hopkins faculty in 1999. He is internationally known both for his clinical research in CFTR modulators and for his work to improve care for adults with cystic fibrosis. While at Johns Hopkins he has received numerous honors including the American Lung Association’s George Comstock Career Achievement Award, American Federation of Clinical Research Achievement Award, “Patient’s Choice Award”, “Best Full-Time Faculty Teacher”, and “Best Doctors in America”. Dr. Boyle is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Secondary Immunodeficiency (SID), Cystic Fibrosis, and Newborn Jaundice.